Dimension scores are derived from public data and fields; weighted into the composite. Reference only.
Feasyfy is a clinical research feasibility survey application developed and sold by Clinovate NET GmbH & Co KG. It primarily serves sponsors and CROs, helping them send online questionnaires to medical centers, hospitals, and universities to assess whether they are willing or able to participate in clinical trials. It is not a general-purpose survey tool; rather, it is a vertical SaaS/enterprise software product built around site selection, invitations, status tracking, and report generation before a clinical trial begins.
The key capabilities disclosed on the site include creating online survey invitations within a project, connecting sponsors, CROs, and medical centers in a multi-tenant setup, and tracking key parameters such as invitations, questionnaires, and statuses in a dashboard. The system can also automatically generate electronic reports, with configurable results and KPIs. For team collaboration, the available text only mentions multi-tenancy and coordination among different participants; it does not publicly detail role-based permissions, approval workflows, audit logs, or granular access controls.
The official website does not disclose plans, pricing, billing models, a free version, or trial information. It only provides registration and login entry points, so buyers need to confirm commercial terms with the vendor before procurement. The deployment model is also not specified—whether it is cloud-only, self-hosted, or hybrid. Third-party integrations, APIs, and developer support are not mentioned in the main content. Although the vendor itself offers healthcare IT services such as EDC, Identity Services, and Medical Coding Tools, this should not be taken as evidence that Feasyfy already provides open integration capabilities.
Feasyfy’s main strength lies in its compliance background. The vendor states that its quality management follows ISO9001 and ISO27001, and that it obtained ISO27001 certification in 2023; employees are trained and use SOPs; and Feasyfy, as part of the cvEDC system, has been included in the computer system validation process. Its EDC system is based on the CDISC ODM standard and references frameworks such as GCP, GMP, GAMP, and FDA CFR Part 11. This information is particularly important for drug clinical trial scenarios.
Its advantages are a focused use case, support for clinical trial site feasibility surveys, dashboards and KPI reporting, plus the backing of healthcare IT experience and a compliance framework. The drawbacks are the lack of public information, especially around pricing, deployment, APIs, integrations, permissions, and data hosting details. The website is primarily in German, so international teams may need language support. It is best suited to sponsors, CROs, and research coordination teams in Germany and the broader European market that need a standardized process for site feasibility surveys.
Access from mainland China cannot be determined from the webpage alone and should be marked as unknown; payment methods are also not disclosed. Chinese teams considering procurement should pay particular attention to network connectivity, cross-border data transfer, contract currency, invoicing, and compliance requirements. Comparable options include Medidata, Veeva Vault Clinical, OpenClinica, Castor EDC, REDCap, as well as domestic clinical trial management, EDC, or site feasibility survey systems.
⚠ This review is compiled from public sources and does not constitute a purchase recommendation. Verify all facts on the vendor's official site. Verify on feasyfy.net official site.
feasyfy.net is an Germany SaaS provider. TG4G tracks its product information, an overall rating of 5.0/10, and a China-accessibility score of Limited (proxy recommended). Click "Visit Official Site" to reach feasyfy.net directly.